Pentosan polysulfate is a white, odorless powder that is used as an oral medicine in the form of a tablet or capsule. It is a polymer that contains two sulfate groups on each carbohydrate monomer. Pentosan polysulfate has a fibrinolytic and anticoagulant effect. Pentosan polysulfate is known by various names such as elmiron, comfora, polypentose sulfate, and pentosan sulfuric polyester. Pentosan polysulfate is sold commercially by the name Elmiron in the U.S., Japan, and many other regions, globally. It is known as Comfora in India. Pentosan polysulfate works as an anticoagulant or blood thinner to prevent the formation of blood clots. It is mainly used to relieve thrombi and bladder pain syndrome (BPS) or interstitial cystitis (IC). It is also used to treat pain that may occur during and/or after sexual intercourse.
Pentosan Polysulfate Drug for Knee and Bone Pain
Pentosan polysulfate is a semi-synthetic polysulfated xylan that is used for the treatment of various human and pet medical conditions such as interstitial cystitis (IC) and thrombi in humans, and osteoarthritis in horses and dogs. In addition, it is also used to cure knee and bone pain. Australian Football League (AFL) players are given pentosan polysulfate for knee and bone pain. Due to these factors, the pentosan polysulfate market is expected to surge in the near future.
Pentosan Polysulfate: Market Segmentation
On the basis of drug type, the global pentosan polysulfate market has been segmented as –
- Human Drugs
- Pet Care Drugs
On the basis of form, the global pentosan polysulfate market has been segmented as –
On the basis of distribution channel, the global pentosan polysulfate market has been segmented as –
- Store-Based Retailing
- Pharmaceutical Stores
- Medical and Health Care Stores
- Online Retailing
Pentosan Polysulfate Market: Key Players
Some of the key players operating in the global pentosan polysulfate market are Janssen Pharmaceuticals, Inc., Caps Pharma Limited, Swati Spentose Pvt Ltd, RAVI SPECIALITIES PHARMA PVT LTD, Life Relay Health Care Solutions Inc., Navamedic ASA, Allcarepharmacy Limited, Reva Pharmachem (P) Ltd., Ortho McNeil Pharmaceutical, Arthropharm PTY Ltd, Ogene Systems (I) Pvt., CVS Pharmaceuticals Private Limited, and NORDIC DRUGS. Besides them, many other drug and chemical manufacturers and industrialists are showing keen interest in the pentosan polysulfate market.
Opportunities for Market Participants
Due to the growing number of bladder pain syndrome (BPS) patients all over the world, the demand for pentosan polysulfate is rising, globally. Pentosan polysulfate is used to treat blood clots, a disease commonly known as thrombi. This drug is also given to the Australian football players for knee and bone pain. Hence, to cure knee and bone pain, it can be given to other sports persons and ordinary people too. As such, companies could focus on these factors to boost the consumption of pentosan polysulfate, globally. Pentosan polysulfate is also used to treat diseases in animals such as osteoarthritis in horses and dogs, which is a good opportunity for new and existing pentosan polysulfate market players. Due to these factors, it is expected that the pentosan polysulfate market would grow substantially in the coming years.
Pentosan Polysulfate: Regional Outlook
The consumption of pentosan polysulfate or elmiron is high in North America, Asia Pacific, and Europe. The reason behind the high consumption of pentosan polysulfate in North America is the increasing number of IC patients. The major producers of pentosan polysulfate are the United States and Japan where it is commercially available in the market by the name elmiron. India is also a major producer of pentosan polysulfate, it is commonly known as comfora in India. Pentosan polysulfate is widely used for bladder pain syndrome in the US, Japan, and India. So, bound to all the above factors, it can be expected that the global pentosan polysulfate market would escalate in the upcoming years.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.